INTI

Inhibitor Therapeutics (QB) (INTI)

Inhibitor Therapeutics Inc (QB)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:INTI

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	02:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/17	02:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/17	02:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/17	02:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/17	02:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2024/05/13	22:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/12/14	20:02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/10/18	22:54	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/08/30	04:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/08/30	03:42	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/08/30	03:33	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/08/11	22:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/06/01	05:31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/24	01:50	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/23	04:45	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/18	19:02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/18	08:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/18	08:11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/18	08:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2023/05/15	22:04	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2022/12/20	07:01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2022/11/15	06:39	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2022/09/16	06:07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2022/05/13	22:02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2022/03/30	22:02	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2021/11/12	23:02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2021/05/14	22:02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2021/03/26	22:03	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2021/01/20	03:51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)
2021/01/07	06:31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:INTI	Inhibitor Therapeutics Inc (QB)